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ABSTRACT
RNA-binding motif protein 20 (RBM20) is a cardiac
splice regulator that adapts cardiac filling via its di-
verse substrates––including the sarcomeric protein
titin. The molecular basis and regulation of RBM20-
dependent exon exclusion are largely unknown. In
tissue culture experiments, we show that the com-
bination of RNA recognition motif (RRM) and C-
terminus is necessary and sufficient for RBM20 ac-
tivity, indicating an important function of the ZnF2
domain in splicing repression. Using splice reporter
and in vitro binding assays targeting titin exons 241–
243, we identified a minimal genomic segment that is
necessary for RBM20-mediated splicing repression
of the alternative exon. Here, RBM20 binds the cluster
containing most RBM20 binding motifs through its
RRM domain and represses the upstream and down-
stream introns. For subsequent exon exclusion, spe-
cific regions upstream, downstream and within the
alternative exon 242 are required. Regulation of exon
exclusion involves PTB4 as a novel titin splice regu-
lator, which counteracts RBM20 repressor activity in
HEK293 cells. Together, these mechanistic insights
into the regulation and action of RBM20 and PTB4
provide a basis for the future development of RBM20
modulators that adapt titin elasticity in cardiac dis-
ease.
INTRODUCTION
Alternative splicing plays a major role in regulating gene
expression by generating protein isoforms with distinct bi-
ological properties (1). The diversity of the resulting pro-
teome relates to altered protein–protein interactions, sub-
cellular localization or catalytic activity. Disrupted fine tun-
ing of the alternative splicing process can cause disease or
affect disease progression and severity (2,3).
Splicing is performed by a complex macromolecular
machine––the spliceosome, which is composed of five
uridine-rich small ribonucleoprotein particles (snRNPs)
and several non-snRNP proteins (4). Major functions of
the spliceosome are to integrate regulatory signals and to
catalyze the splicing reaction. Multiple cis-acting RNA ele-
ments within the pre-mRNA act as splicing signals. They
define exon/intron borders, which are recognized by the
splicing machinery (the 5′ and the 3′ splice sites (ss), branch
point and the polypyrimidine tract). 5′ss recognition occurs
through RNA–RNA base pairing when the 5′ss sequence
is bound by the 5′ end of U1 snRNA. On the other side of
the intron the 3′ss is defined by non-snRNP factors such as
SF1/mBBP interacting with the branch point and U2AF
associating with the polypyrimidine tract and the 3′ss. The
characterization of spliceosome assembly intermediates in
vitro suggests a carefully orchestrated process (5). Spliceo-
some assembly starts with the recognition of the 5′ss by
the U1 snRNP, proceeds with the recruitment of the U2
snRNP to the 3′ss and juxtaposition of splice sites, and con-
tinues with the recruitment of the U4/U5.U6 tri-snRNP,
rearrangement of RNA–RNA and RNA–protein interac-
tions and finally splicing catalysis (6).
Splicing regulation is frequently executed at the early
events in splice site recognition, by positively or negatively
affecting U1 snRNP/U2 snRNP recruitment to 5′ and 3′ss,
respectively (7). Exon definition by binding of U1 and
U2 snRNP to 5′and 3′ splice sites and subsequently pair-
ing commits the pre-mRNA to the splicing pathway (8).
Recognition of splicing signals and exon and intron def-
inition are regulated by cis-acting RNA elements known
as splicing regulatory elements. Exonic/intronic splicing
enhancer/silencer sequences are bound by SR proteins
(serine/arginine-rich) and the hnRNPs (heterogeneous nu-
clear riboproteins), which canonically promote and repress
splicing, respectively (9).
The SR protein RBM20 (RNA binding motif protein 20)
regulates isoform expression of the sarcomeric protein titin
(TTN) and several other cardiac proteins (10). It is pre-
dominantly expressed in striated muscle with highest lev-
els in the perinatal heart and was identified in a naturally
occurring mutant rat deficient in titin splicing (10). Here,
RBM20 deficiency leads to predominant expression of the
highermolecular weight giant titin isoformN2BA-G aswell
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as the N2BA isoform (10). The former is expressed in em-
bryonic development, while the adult N2B and N2BA titin
isoforms are expressed at ratios that vary between species
and in healthy versus diseased hearts (11). These isoforms
mainly differ in the I-band region, which determines the
elastic properties of titin. The RBM20-deficient rats mir-
ror the pathological features of patients deficient in RBM20
with left ventricular dilation, progressive subendocardial fi-
brosis and sudden death (10,12–13).
In addition to adapting titin isoform expression and thus
cardiac filling in diastole, RBM20 affects a set of>30 genes,
which have been implied in diastolic function, sarcomere
assembly and ion transport. It regulates different types of
alternative splicing, namely exon repression, mutually ex-
clusive exon selection, exon inclusion, intron retention and
exon shuffling (10,14–15). High-throughput analysis has
identified UCUU as the RBM20 binding motif as well as
RBM20 binding proteins that relate to early spliceosome
formation (15), but how RBM20 leads to exon exclusion is
largely unknown.
The splice factor PTB4 (alias PTBP1 or hnRNPI) is a
member of the hnRNPs and can promote exon inclusion
(16). It is expressed in the heart, skeletal muscle and the
brain and is important for early embryonic development as
the knockout is lethal (17).
In this study we characterize the molecular basis of
RBM20-dependent alternative exon exclusion. We find
RNA recognition motif (RRM) and C-terminus of RBM20
and a 994-nt minimal genomic region within the titin pre-
mRNA essential to repress splicing. The minimal region
contains exon 242 and its flanking introns and is neces-
sary and sufficient for RBM20-mediated splicing regula-
tion. In addition, RBM20 interferes with the removal of the
upstream and downstream introns to prevent inclusion of
titin exon 242. Mechanistically, the RRM of RBM20 binds
to the downstream intronic region of the minimal genomic
segment described above, where it competes with PTB4 to
antagonistically affect exon inclusion.
MATERIALS AND METHODS
Molecular cloning
The titin expression construct (TTN241-3) was cloned
by inserting human genomic titin fragment (GenBank
NC 000002.12, chr2: 178622670–178625396), containing
titin exons 241–243 together with intervening introns, into
the pcDNA3.1zeo vector (Invitrogen). Exon 242 is part of
I-band region of titin. Subsequent deletion mutants were
created by polymerase chain reaction (PCR)-based gene as-
sembly (please contact authors for primer sequences). The
human hemoglobin beta expression construct was cloned
by inserting a fragment containing exons 1–3 and inter-
vening introns into the vector pcDNA3.1zeo (Invitrogen).
Subsequent deletion mutants were created by PCR ampli-
fication and cloned into the same vector. Hybrid human
titin/human beta globing constructs were created by sub-
cloning PCR-amplified fragments into the pcDNA3.1zeo
vector (Invitrogen). We cloned human RBM20 (the acces-
sion number in NCBI is NM 001134363) and its mutants
as cDNA into pcDNA3.1(-)A-myc-his viaNheI/KpnI sites.
The RBM20-RRM (aa 511–601) was cloned into pGEX-
6P-1 via BamHI/XhoI sites.
For all cloning amplifications we used the proofreading
DNA polymerases (Phusion or Q5 from NEB) and final
constructs were sequence-verified.
Cell culture and transfection
We cultured HEK293 cells in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with 10% (v/v) Fetal
Bovine Serum (FBS), 100 U/ml penicillin and 100 ug/ml
streptomycin. We used PEI40 (HEK293 cells) or Lipofec-
tamine 2000 (Invitrogen) (C2C12, H9C2 cells) to trans-
fect plasmids in DMEM without antibiotics (20 min com-
plex formation, 48 h incubation). For cotransfection with
RBM20 and PTBs we used equimolar ratios. DNA/PEI40
ratio of 1:3 at 1 g DNA/per well was used for transfec-
tion of a 6-well dish. Total RNA was collected 48 h after
transfection.
RNA isolation, RT- and qRT-PCR (SYBR Green)
To isolate total RNA from cells, we used Trizol (Invitro-
gen). Preparations of <2 g of total RNA were treated
with DNase I (Thermo Fisher Scientific), according man-
ufacturer instructions. For first-strand cDNA synthesis, we
used random octamers and oligo dT-16 primers andMuLV
reverse transcriptase (High capacity RNA-to-cDNA kit,
Thermo Fisher Scientific). PCR amplification was limited
to 30 cycles with 60◦C annealing temperature. We sepa-
rated the PCR products on 3% agarose gel. PCR primer
sequences are provided in the Supplementary Table S1. All
experiments were repeated three times.
Quantitative reverse transcriptase-PCR (qRT-PCR) was
performed using SYBRGreen master mix (Applied Biosys-
tems) in a 7900 HT cycler (Applied Biosystems). qRT-PCR
primers are listed in Supplemental Table SII. The quan-
tification of the gene expression was performed using the
CT method. Relative levels of splice isoforms are pre-
sented as a ratio of mRNAs, with exon 242 included, ver-
sus mRNAs, with exon 242 skipped. The fold change in
inclusion/skipping ratio was obtained when compared to
the control (transfection with RBM20 expressing plasmid).
n= 3 for all samples, all data are expressed as mean± SEM.
Group comparisons were analyzed by one-way ANOVA
and Bonferoni post test. P values were considered statisti-
cally significant as follows: *P < 0.05; **P < 0.01; ***P <
0.001.
In vitro transcription
Amplified PCR products were used as templates for in
vitro transcription. Each template was generated using a
forward primer containing a T7 polymerase promoter se-
quence [GGG to provide an efficient initiation site for tran-
scription] and a sequence complementary to the beginning
of the template. The reverse primer was complementary to
the last nucleotides of a template. The PCR products were
purified (MSB Spin PCR Rapace, Stratec Molecular) and
used as templates for in vitro transcription. Uncapped, 32P-
labeled transcripts (rUTP as the labeled nucleotide) were
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synthesized by in vitro run-off transcription from the puri-
fied PCR templates using T7 RNA polymerase (Promega).
Primer extension assays with splice junction oligonucleotides
Primer extension assays with splice junction oligonu-
cleotides were carried out as described (18). Total RNA
was extracted from for 48 h transfected HEK293 cells, en-
riched for mRNA using Promega PolyATract mRNA Iso-
lation Systems III and IV kit (Cat Z5310) and ∼2 g of
mRNA used to carry out primer extension assay with indi-
cated single 5′-labeled oligonucleotide (listed in Supplemen-
tary Table SIV).
Western blotting
We harvested transfected cells and lysed them in Radioim-
munoprecipitation assay (RIPA) buffer. Protein concen-
tration was measured using the BCA kit (Bicinchoninic
Acid Assay - Thermo Scientific). We loaded 50 g (or 100
g) of total protein in a well. Proteins were separated by
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and subjected to immunoblotting. Mem-
branes were probed with mouse antibodies against anti-
c-Myc (13–2500, Invitrogen) and anti--Tubulin (DM1A,
Calbiochem). The secondary antibody was HRP-conjugate
anti-mouse IgG (H+L) (Calbiochem). For detection, we
used an ECL kit (Thermo Scientific).
Recombinant proteins
Recombinant GST-tagged proteins were expressed in Es-
cherichia coli Rosetta 2 strain (Novagen). Proteins were
purified under native conditions by standard GST affinity
chromatography, as described by themanufacturer (Sigma).
Purified proteins were cleaved from the GST-tag with
PreScission protease (GE Healthcare) and dialyzed against
20 mM HEPES (pH 7.9), 100 mM KCl, 20% glycerol,
0.2 mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM
Dithiothreitol (DTT) buffer and stored at −80◦C. Quality
of purification was assayed on an SDS-gel (protein marker
PageRuler Prestained Plus Protein Ladder from Thermo
Scientific was used) and the final protein concentration was
determined using NanoDrop (Thermo Scientific).
Gel mobility shift assays
Each gel mobility shift reaction (10 l) contained: 20 mM
HEPES pH 7.9, 100 mM KCl, 3.2 mM MgCl2, 0.2 mM
EDTA, 0.25 mM DTT, 15% glycerol, tRNA (1 mg/ml),
heparin (0.5 mg/ml), the RNA probe (50 000 cpm, ∼10
fmol) and recombinant protein, where indicated recombi-
nant human RBM20-RRM (50 nM–1M). RNA probes
were denatured at 80◦C for 5min and put on ice.All reaction
components were mixed and incubated for 10 min at 30◦C,
then placed on ice and separated on an 8% native poly-
acrylamide gel. The apparent Kd was estimated as the con-
centration of protein where the RNA was half bound (19).
Gel mobility shift assays using recombinant PTB4were per-
formed as described (19).
RESULTS
Identification of the genomic sequence necessary for RBM20-
mediated titin exon 242 repression
We previously reported a role for RBM20 in regulating
cardiac isoform expression, including conservation of tar-
get exons within titin (10). To study the molecular basis
of RBM20-dependent titin exon exclusion, we based our
analysis on human TTN exons 241–243, which is part of
titin’s I-band region––a main determinant of the elastic
properties of the titin filament. The exon/intron cassette
was transcribed under control of the CMV promoter (splic-
ing reporter TTN241-3, Figure 1A). Transient transfection
of TTN241-3 with or without human RBM20 expression
resulted in a splicing pattern consistent with our predic-
tions from the RNAseq analysis of rat and human car-
diac transcriptomes (10) in all cell-lines tested (Figure 1B).
RBM20 repression activity inHEK293 cells (human fibrob-
lasts) appeared to be higher than in mouse or rat myoblasts
(C2C12 or H9C2 cells) (Figure 1B). Accordingly, we se-
lected HEK293 cells to study RBM20-mediated cassette
exon repression and demonstrated that RBM20 is sufficient
to regulate the alternative splicing of this pre-mRNA us-
ing quantitative reverse transcriptase-polymerase chain re-
action (qRT-PCR). In vivo, this region responds to RBM20,
as TTN exons 241–243 are differentially regulated in the
RBM20 deficient rat heart (Supplementary Figure S1E).
To identify the minimal RBM20 responsive genomic seg-
ment within the TTN exons 241–243, we constructed a se-
ries of TTN241-3 deletionmutants. In the first set of mutants,
depicted in Figure 1C,we sequentially deleted∼100 bp frag-
ments from the TTN241-3 upstream intron (Figure 1C, splic-
ing reporter 1, 2 and 3). Although the repression was
slightly increased, none of these deletions dramatically af-
fected RBM20-mediated exon repression (Figure 1D). As
indicated by quantification of the PCR products, alterna-
tive exon exclusion varies between 75 and 90% (Figure 1D,
reporter TTN241-3). However, exchanging the last 146 nt of
the upstream intron for the corresponding sequence of the
human -globin gene first intron resulted in a complete loss
of RBM20 response (Figure 1C, reporter X1), underscoring
the absolute requirement of this region for exon repression.
We applied the same approach to the downstream intron
of the TTN241-3 reporter and found that a 910 nt long seg-
ment of the downstream intron, starting directly after the
5′ss, is required to retain RBM20 repressor activity (Figure
1E, reporter 6). Neither a 118 nt segment, nor a 466 nt
were sufficient to mediate exon repression (Figure 1E, re-
porters 4 and 5). Subsequent deletions within the iden-
tified 910 nt long segment, retained repressor activity (Fig-
ure 1E, reporters 7 and 8). However, repression was not
as efficient as with the splicing reporter, containing the full
length fragment. Retaining sequences toward the middle of
the downstream intron resulted in the activation of a cryptic
5′ss (Figure 1E, reporter 9; usage of the cryptic splice site
was confirmed by sequencing).
Based on these results wemaximally downsized upstream
and downstream introns to create a TTN241-3 mini reporter
(Figure 1G, 10). The response of the 10 reporter to
RBM20 is slightly stronger than the full-length reporter (in
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Figure 1. Human titin-derived splicing reporters respond to RBM20-
mediated splicing repression in cell culture. (A) The splicing reporter
TTN241-3 contains the human titin (TTN) genomic sequence from exon
241 to 243. Exon 242 is excluded in the presence of RBM20. Alternative ex-
Figure 1H; TTN241-3 versus10). The band above the three
joint exons-band (Figure 1H, lane 3) retains the intron se-
quence (verified by sequencing) and probably reflects re-
moval of ISE sequences from this intron. Creation of an
additional titin mini reporter, containing only 118 nt of the
downstream intron (Supplementary Figure S1C), conveyed
insufficient repressor activity of RBM20 (Supplementary
Figure 1D compare TTN241-3 and 15). To identify the po-
tential ISE region in the upstream intron we created the sec-
ond set of mutants where we gradually re-inserted ∼150 bp
long fragments from the original upstream intron (Supple-
mentary Figure S1A, reporters12,13 and14). Repres-
sion activity of the mutant splicing reporters was slightly in-
creased compared to the wild-type (WT) reporter (Supple-
mentary Figure S1B), suggesting that we did not eliminate
sequences from the upstream intron that are essential for
splicing repressor activity. Our deletion mutants within the
upstream intron address splicing activation activity to the
region between nt 278 and 440 (Supplementary Figure S1B,
reporter14 versus11), as this reporter preferably spliced
out the upstream intron sequence rather than included them
(results confirmed by sequencing RT-PCR products).
Collectively these results indicate that a human titin ge-
nomic segment containing the regulated exon with the 102
and 910 nt of the upstream and downstream introns, respec-
tively, is sufficient to mediate RBM20-dependent exon re-
pression in cell culture.
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
ons are represented as light boxes, constitutive exons as dark boxes and in-
trons as lines (bp= base pairs). (B) Validation of RBM20-dependent alter-
native splicing byRT-PCR. Transient transfection ofHEK293, C2C12 and
H9C2 cells with the TTN241-3 and empty vector (−) or a plasmid express-
ing human RBM20 (+) produces the expected RT-PCR products––with
and without the alternative exon 242 (top and bottom band, respectively).
Quantification of three independent transfections are shown as percent-
ages of mRNA excluding the alternative exon. (C) TTN241-3 deletion mu-
tants, generated to identify the RBM20-responsive splicing repression ele-
ment in the upstream intron. Dotted lines represent deleted sequences and
the blue line a sequence replacedwith the first intron of the human-globin
gene. (D) Analysis of RBM20-dependent alternative splicing by RT-PCR
in HEK293 cells transiently transfected with each reporter construct, as
indicated. The RT-PCR product at 268 bp represents mRNA species that
does not contain exon 242. Ratio of exon inclusion/exclusion was reduced
to 4% only in the X1 replacement construct, while deletion in construct3
enhances the RBM20 effect (quantification of three independent transfec-
tions). (E) TTN241-3 deletion mutants generated to identify the RBM20-
responsive splicing repression element in the downstream intron. Dotted
lines indicate deleted sequences. (F) Analysis of RBM20-dependent alter-
native splicing of deletion constructs affecting the downstream intron of
TTN241-3. Constructs where deletions extend into the mid intronic region
(4 and 5, indicated with a gray box) reduce their repressor activity to
<10% and7 to<30%. Presence of themid intronic region (indicatedwith
a black box, construct 6) restores repressor activity (quantification of
three independent transfections). (G) TTN241-3 deletionmutants generated
to integrate the information on splicing responsive elements and truncate
the minigene for subsequent analysis. Thin (gray) lines indicate TTN se-
quences, dotted lines indicate deleted sequences. (H) Analysis of RBM20-
dependent alternative splicing of deletion construct affecting both the up-
stream and the downstream introns of TTN241-3. RBM20 responsiveness
is maintained in construct 10 that lacks >50% of the downstream intron
sequence (quantification of three independent transfections).
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A 994 nt titin genomic segment is sufficient to convert a hu-
man -globin cassette into an RBM20 responsive splicing re-
porter
To confirm that the identified titin genomic segment is suf-
ficient to mediate a RBM20 response, we inserted it into
an RBM20 independent splicing reporter derived from the
human -globin gene, replacing the alternative exon and
flanking intronic regions (Figure 2A, reporter X6). The hu-
man -globin splicing reporter itself (Figure 2A, BG) or
its derivative with a shortened second intron (Figure 2A,
BG) did not respond to RBM20 (Figure 2B). In the first
set ofmutants (Figure 2A), we tested the length requirement
of the downstream intron segment for RBM20-mediated
splicing repression. The length of the upstream intron seg-
ment was kept constant at 64 nt. Reduction of the down-
stream intron segment from 910 to 662 nt retained repressor
activity of RBM20 (Figure 2B). Short 59 to 118 nt stretches
of the downstream intron were not sufficient to efficiently
support RBM20-mediated exon repression (Figure 2B, X2
and X3). Exon repression activity with the first 598 nt of the
downstream intron included in the reporter was intermedi-
ate (Figure 2B, reporter X4).
After our demonstration that the flanking titin exons
241 and 243 are dispensable for RBM20-mediated exon re-
pression, we evaluated if the upstream intronic region is
sufficient to mediate RBM20-dependent exon repression.
We created one mutant where only the downstream in-
tron and exon 243 sequences in the TTN241-3 reporter were
exchanged to -globin (Figure 2C, reporter X7) and one
where only exon 242 from titin was present in the -globin
splicing reporter (Figure 2C, reporter X8). None of these
constructs responded to the addition of RBM20 (Figure
2D), demonstrating that exon 241, upstream intron and
exon 242 sequences did not contain RBM20-responsive
repressor elements. In addition, we moved a stretch of
3′ intronic titin sequence which contains several RBM20-
responsive repressor elements closer to the 5′ss (Figure 2E).
However, only the insertion of the complete 3′ titin in-
tronic sequence up to nt 750 results in a reporter that ef-
ficiently responds to RBM20 (Figure 2F), suggesting that
the downstream intron sequence architecture is important
for RBM20-mediated exon repression.
To investigate the requirement of exon 242 and the up-
stream intron sequences for RBM20-mediated exon repres-
sion, we exchanged titin exon 242 with -globin exon 2 se-
quence except for the last 13 or 75 nucleotides upstream of
the 5′ss (Figure 2G, X12 or X13, respectively). We find exon
repression dependent on the exon 242, as inclusion of only
13 or 75 nt from this exon completely eliminates RBM20-
mediated exon repression (Figure 2H, X12 and 13 versus
X11, 14 and 15). Inclusion of the full exon 242 sequence res-
cues RBM20-mediated exon repression, but is not sufficient
to achieve the repression level of the identified minimal ge-
nomic segment (Figure 2H, X14 versus X11). At least 64 nt
from the upstream intron sequence is required for RBM20-
mediated exon repression (Figure 2H, TTN241-3 versus X15
and 11). qRT-PCR analysis was performed to confirm sig-
nificant differences in repressor activity of X15 and X11
splicing reporters (Supplementary Figure S2A).
To investigate the requirement of exon 242 for RBM20-
mediated repression of this exon, we gradually removed se-
quences from the middle of exon 242 (Figure 2I, X16–X19).
This reduces exon 242 length from 267 to 200, 150, 100 and
41 nt in the respective mutants. In X16 the 41 nt exon was
not recognized as flanking exons were joined together (Fig-
ure 2J). All the other shortened exons were recognized as
being exons, but none of these splicing reporter mutants
responded to RBM20 with the same exon repression effi-
ciency as the reporter X5 containing the WT exon 242. To
differentiate a size from a sequence effect, we exchanged
exon 242 titin sequence with sequences derived from the
bacterial lacZ gene (Figure 2K, X20–X22). Supplemented
to its natural length of 267 nt, the hybrid titin-lacZ exons
did not support efficient RBM20 dependent exon removal
(Figure 2L, X20 and X21). As the exon was extended to
more than 1000 nt in length, it was no longer recognized by
the splicing machinery as an exon and resulted in the splic-
ing pattern where the flanking exons were joined together
(Figure 2L, X22).
In summary, the 994 nt-long human titin genomic seg-
ment is sufficient to convert the human -globin splicing
reporter into an RBM20-responding splicing reporter and
suggests that both flanking introns and the alternative exon
sequence are required for the repression activity in RBM20-
mediated splicing regulation.
Both the RRM and the carboxy-terminal region of RBM20
are necessary for exon repression
The domain structure of RBM20 is conserved between
species (10) and includes an amino-terminal domain of un-
known structure and function, a central part with zinc fin-
ger 1 (ZnF1), RRM-type RNA binding domain (RRM)
and an arginine-serine (RS) repeat-containing region and
the carboxy-terminal domain with ZnF2 (depicted in Fig-
ure 3A) (10).
We used transient transfections to examine which
RBM20 protein regions are required for splicing repressor
activity. We created a set of RBM20 deletion mutants (Fig-
ure 3A) and transfected HEK293 cells with the TTN241-3
reporter (Figure 1A) and the RBM20 mutants. The effect
on splicing repression examined by the RT-PCR (Figure
3B). All RBM20 deletion mutants localized to the nucleus
of HEK293 cells (Supplementary Figure S3B) and had the
expected molecular weight as determined by western blot
(Supplementary Figure S3A). The alternative exon 242 in
the TTN241-3 reporter was predominantly included when
splicing reporter was co-transfected with vector alone or
deletion mutants C-terminal of the RRM/RS domain. It
was predominantly excluded with the N-terminal deletion
construct (Figure 3B). Removal of the RRM or RS do-
main completely abolished the repressor activity (Figure
3B, RBM202, 3, 6, 8), indicating that the RRM and RS
domains are necessary but not sufficient for splicing repres-
sion. Mutants with residual activity were evaluated using
qRT-PCR (Figure 3C, RBM204, 5, 7) and apart from
the essential RRM and RS domain, the ZnF2 domain had
the strongest residual effect on the repressor activity of
RBM20.
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Figure 2. Transfer of RBM20 responsiveness from the titin to the -globin splicing reporter by gradual exchange of the middle exon and the flanking intron
regions. (A)Human titin/-globin hybrid splicing reporters generated to analyze theminimal titinRBM20-responsive repressor element in the heterologous
contents. Hybrids contain increasing amounts of TTN genomic segments (gray) inserted into the human -globin minigene (exons 1–3 with interfering
introns, blue; exon numbers on top). The gray bar indicates the RBM20 responsive region, the dispensable region in black. (B) RT-PCR validation of
RBM20-mediated changes in splicing of human titin/-globin hybrid splicing reporters X2–X6. The relative amount of mRNA excluding the alternative
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Taken together, the activity of RBM20 depends on the
RRM and RS domains, necessary but not sufficient for
exon exclusion. The addition of the C-terminus including
the ZnF2 is sufficient for the repressor activity of RBM20.
RBM20-RRM binds to sequences within the minimal repres-
sion segment
The RNA binding motif of RBM20 contains a UCUU
core (15). In a systematic approach we used gel-shift assays
on serial truncations of the reporter construct to identify
the minimal repression segment. The in vitro transcribed
and uniformly radiolabeled RNA was exposed to increas-
ing amounts of purified recombinant protein containing
the RBM20-RRM domain (RBM202, residues 511–601;
Supplementary Figure S3A) followed by separation on non-
denaturing acrylamide gels. The 994 nt RBM20-responsive
RNA segment was divided into the upstream intron tran-
script (A), the exon (B) and serial downstream intron tran-
scripts (Figure 4A). RBM202 bound with highest affinity
to transcripts C and D. RBM202 did not bind any other
segments––independent of the number of consensus sites.
A minor shift of transcript B when the highest RBM202
concentration was applied (Figure 4B) was reevaluated us-
ing shorter B-derived transcripts, but none of them bound
RBM202 (Supplementary Figure S4B). C and D tran-
scripts are situated immediately downstream the regulated
exon and contain the most of the predicted RBM20 bind-
ing motifs (Figure 4A). Thus, RBM20 binds predominantly
to an ∼300 nt RNA segment downstream of the regulated
exon 242, which contains eight potential RBM20 binding
motifs. The UCUU motif is sufficient for RBM202 bind-
ing specificity (Supplementary Figure S4C). To support
our identification of the relevant motives, we introduced
pointmutations inTTN intron 242–243 eliminating the four
UCUU motifs proximal to the 5′SS as potential RBM20
binding sites (Supplementary Figure S4D). Elimination of
the first UCUU motif (mut1) had the strongest effect on
RBM20-dependent alternative exon exclusion (Supplemen-
tary Figure S4E). However, this mutation was not sufficient
to eliminate RBM20-mediatd exon exclusion (Supplemen-
tary Figure S4E). The remaining mutations (mut2, mut3
and mut4) had minor or negligible effects. RT-PCR results
were confirmed by qRT-PCR (Supplementary Figure S4F).
RBM20 prevents exon 242 inclusion by interfering with the
removal of the upstream and downstream introns
So far, we demonstrated that exonic and flanking intronic
sequences are necessary and addition of RBM20 is suffi-
cient to cause exon 242 skipping. Based on thesis findings,
we hypothesized that RBM20 simultaneously represses
splicing of both individual flanking introns to exclude the
alternative exon.
Building on established protocols (20), we used tran-
sient transfection of the TTN241-3 splicing reporter into the
HEK293 cells followed by qRT-PCR to quantify splicing
intermediates, where only one of two exon–exon junctions
are generated (Figure 5A). Addition of RBM20 prevented
splicing of both introns (Figure 5B and C). After addition
of RBM20 the splicing intermediate lacking the down- or
upstream intron were decreased 2- or 8-fold, respectively
(Figure 5B and C). In contrast, addition of PTB4, which
binds the same consensus motif as RBM20, differentially
affected the splicing of the introns flanking titin exon 242:
PTB4 increased the splicing intermediate lacking the down-
stream intron ∼6-fold (Figure 5D) with a minor decrease
of the intermediate lacking the upstream intron that did
not reach significance (Figure 5E). As the size of RBM20
and the minimal splicing reporter precluded their use in an
in vitro splicing reaction (compare supplementary methods
and Supplementary Figure S5A), we analyzed the accumu-
lation ofmRNAproducts, resulting from the cotransfection
of TTN241-3 splicing reporter withRBM20, PTB4 or control
into the HEK293 cells (Figure 5F and G). The mRNA was
enriched, reverse transcribed and used for primer extension
analysis (Figure 5F). The size of the resulting product was
consistent with exclusion of the alternative exon 242 after
addition of RBM20, but not after addition of PTB4 (Fig-
ure 5G). RBM20 dramatically reduced accumulation of the
primer extension product over the downstream intron and
slightly reduced upstream intron primer extension product
accumulation, while PTB4 had no or the opposite effect.
The accumulation of splicing intermediates and products,
resulting from the cotransfection of TTN241-3 splicing re-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
exon was determined for each mutant. Inclusion of intron segment 118–598 restored >20% of RBM20 response (X4). The additional inclusion of 598 to
663 restored >50% (X5) (quantification of three independent transfections). (C) Human titin/-globin hybrid splicing reporters with TTN (gray) and -
globin sequences (blue) to evaluate the contribution of exon 242 and the upstream intron sequence to RBM20-mediated splicing repression. The black bar
indicates the titin region not required for RBM20 responsiveness. (D) RT-PCR validation of RBM20 effects on alternative splicing of the human BG-TTN
hybrid splicing reporters X7–X8. Constructs that contained the titin downstream intron or only the alternative exon with flanking exon definition sites did
respond to RBM20 (quantification of three independent transfections). (E) Human titin/-globin hybrid splicing reporters generated to evaluate the intron
sequences proximal to the 5′splice site for splice repression activity. The 153 nt mid intron segment (illustrated in thin black line) was positioned at indicated
distances from the 5′ss. (F) RT-PCR validation of RBM20-mediated changes in alternative splicing of the human titin/-globin hybrid splicing reporters
X9–X11. Adding the majority of the 3′ intron to the alternative exon with immediate flanking exon definition sites transfers RBM20 responsiveness to
the -globin splice reporter (quantification of three independent transfections). (G) Human titin/-globin hybrid splicing reporters generated to evaluate
the contribution of exon 242 and the upstream intron sequence to RBM20-mediated splicing repression. (H) RT-PCR validation of RBM20 effects on
splicing of the human titin/-globin hybrid splicing reporters X12–X15. Only the combination of complete exonic sequence, flanking region and 750 bp in
the downstream intron restore RBM20 responsiveness (included/excluded >84%, quantification of three independent transfections). (I) Human titin/-
globin hybrid splicing reporters to evaluate the length of exon 242 required for RBM20-dependent splicing repression. The residual length of original exon
sequence is indicated above the exon box. (J) RT-PCR validation of RBM20-mediated changes in alternative splicing of the human titin/-globin hybrid
splicing reporters X16–X19. None of the shortened constructs responded efficiently to RBM20 (quantification of three independent transfections). (K)
Human titin/-globin/lacZ hybrid splicing reporters generated to evaluate the sequence of exon 242 required in RBM20 mediated splicing repression. (L)
RT-PCR validation of RBM20-mediated changes in alternative splicing of the human titin/-globin/lacZ hybrid splicing reporters indicate that exonic
sequence and size contribute to RBM20 responsiveness (quantification of three independent transfections).
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Figure 3. The RBM20 RRM and C-terminus are sufficient for titin splic-
ing repression. (A) Schematic representation of RBM20 and the deletion
mutants. The two zinc finger (ZnF) domains are depicted in blue, the RRM
green, the RS-like domain in orange. Unstructured regions are indicated
as small gray boxes. The WT protein and all deletion mutants carry C-
terminal myc- and his-epitope tags. RBM20 amino acid residues are in-
dicated underneath the schemes and the corresponding molecular weight
of proteins is depicted in brackets. (B) RT-PCR validation of RBM20-
mediated changes in processing the human titin TTN241-3 splicing reporter
in HEK293 cells. Gray boxes represent mRNA species with and with-
out the alternative exon 242 (top and bottom band, respectively). Quan-
tification of three independent transfections are shown as percentages of
mRNA excluding the alternative exon. (C) qRT-PCR (SYBRGreen) anal-
ysis of HEK293 cells transfected with the TTN241-3 splicing reporter and
the RBM20 expression constructs with activity in panel B: n = 3; *P <
0.05; **P < 0.01; ***P < 0.001.
porter with RBM20 or PTB4 into the HEK293 cells was
examined using the S1 nuclease assay. This analysis revealed
that the exon 242–243 product is increased upon addition of
PTB4 (Supplementary Figure S5C), while the exon 241–243
product is increased upon addition of RBM20 (Supplemen-
tary Figure S5D). These findings are consistent with a role
Figure 4. RBM20-RRMbinds to the intron regions downstream of the al-
ternative exon. (A) Schematic representation of the RNA transcripts used
to study RBM202 binding. Titin transcripts were derived from the mini-
mal region necessary for RBM20 function (labeled A–G. Black boxes indi-
cateUCUUbindingmotifs––consensus sites forRBM20binding. (B) RN–
protein complex formation as determined by gel-shift assays. The same
batch of recombinant RBM202 was used to allow direct comparisons
of affinities. Black arrows indicate the RNA–protein complexes.
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Figure 5. Analysis of splicing intermediates of the RBM20-regulated
TTN241-3 splicing reporter. (A) Schematic representation of intermediate
splicing products and arrangement of primer pairs used to quantify splic-
ing intermediates upon RBM20 addition on TTN241-3 splicing reporter.
The pre-mRNA (depicted in the middle) was used for normalization
(primers in red and blue). Primers specific for the intermediate RNAs were
arranged at indicated exon–exon junctions (depicted in black). (B–E) RT-
PCR (SYBR Green) validation of splicing intermediates upon transient
transfection of TTN241-3 splicing reporter with/without RBM20/PTB4-
expression plasmid into HEK293 cells. Splicing intermediates were nor-
malized to the pre-mRNA. n = 3; ***P < 0.001. (F) Splice junction
oligonucleotides to detect the alternative splicing products. (G) Alterna-
tive splicing with or without RBM20 and PTB was analyzed by primer ex-
tension. The expected products of primer extension are indicated. RBM20
suppresses and PTB4 enhances inclusion of titin exon 242.
of RBM20 in repressing the splicing of both upstream and
downstream introns.
Repressor activity of RBM20 is counteracted by PTB4
To investigate whether Polypyrimidine tract-binding
protein (PTB) could regulate alternative splicing of
titin-derived substrates, we first performed transient
co-transfections of PTB and RBM20 together with a
titin/-globin mutant splicing reporter X11 (Figure 6A)
in HEK293 cells and evaluated results by the RT-PCR
(Figure 6B). We included RBM20-expressing plasmids in
our transient transfection at 1:1 ratio with the reporter, to
facilitate detection of the potential enhancing activity of
the test protein. PTB exists in three alternatively spliced
isoforms, PTB1, PTB2 and PTB4, which have distinct
effects on alternative splicing of -tropomyosin (TM)
(21). As PTB2 had an intermediate effect in the repressive
hierarchy (in the transfected smooth muscle cells), we
restricted ourselves in cloning and testing only PTB1 and
PTB4 isoforms. PTBP1 is expressed in HEK293 cells and
in developing rat cardiomyocytes (Supplementary Figure
S6I and J).
Increasing concentrations of transfected PTB4 signifi-
cantly enhanced inclusion of the regulated middle exon in
the X11 splicing reporter (Figure 6B and C; quantifica-
tion in Supplementary Figure S6A and B). Similarly, co-
transfection of equivalent or higher molar ratios of PTB1
did increase inclusion of the regulated exon 242 into theX11
splicing reporter (Supplementary Figure S6C–G). Toward
understanding the molecular basis of PTB4 dependent titin
splicing, we performed in vitro binding assays. Building on
our RBM202 interaction data, we divided TTN 242–243
intron transcript C sequence into ∼30 nt RNAs with sin-
gle, double or no binding motif UCUU (Figure 6D). In-
creasing amounts of recombinant PTB4 protein were incu-
bated with those RNAs and formed mixtures were sepa-
rated on a native gel (Figure 6E). PTB4/RNA complexes
were formed only with RNAs containing UCUU motifs
(C1, C2 and C4 versus C3). Adding increasing amounts
of PTB4 to complexes of RBM202 and RNA contain-
ing two UCUUmotives or only a single UCUU, resulted in
complexes of higher molecular weight than complexes with
RBM20 or PTB4 alone. This suggests simultaneous binding
of PTB4 and RBM20 to transcripts (Figure 6F).
We conclude that both PTB4 andRBM20 bind the intron
downstream of the alternative TTN exon 242 where PTB4
overcomes the repression by RBM20 as summarized in Fig-
ure 7.
DISCUSSION
In this study, we investigated several aspects of alterna-
tive splicing regulation by the RBM20 protein and iden-
tified a 994-nt segment in the TTN pre-mRNA, which is
necessary and sufficient to regulate exon 242 splicing by
RBM20. The segment contains 64 nt from the upstream in-
tron, the regulated exon 242 (267 nt) and 663 nt from the
downstream intron. Additional truncation of this segment
reduced or abolished the RBM20 repressor activity (Fig-
ures 1 and 2), indicating that the whole genomic segment
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Figure 6. PTB4 enhancers TTN exon 242 inclusion dependent on the
downstream intron. (A) Schematic representation of the human TTN
contributes to splicing regulation. Interaction of the 994
nt segment with the RBM20-RRM domain involves a re-
gion immediately downstream of exon 242 which contains
multiple UCUU binding motifs. A stretch of these motifs
is required to mediate RBM20-mediated exon repression as
demonstrated with the deletion analysis of the titin genomic
segment (Figure 2A and B) and confirmed by mutagenesis
gradually eliminating UCUU binding motifs in TTN241-3
downstream intron (Supplementary Figure S4E). Remark-
ably, the RBM20-RRM concentration required to achieve a
gel-shift is lower for region C (immediately downstream of
the alternative exon) versus region D (3′ of region C), which
might indicate that sequences in the proximity to the 5′ss are
bound with the higher affinity than more distal intronic se-
quences. This is consistent with the increased presence of
UCUU motives and a cluster toward the 5′ss. Among the
transcriptome-wide RBM20 binding sites in heart-specific
transcripts identified using HITS-CLIP, intronic RBM20-
binding positions flanking alternative exons correlate with
splicing repression (15). In particular, RBM20 binding sites
were significantly over-represented in a window spanning
400 bp upstream/downstream from the 3′/5′ splice sites of
differentially spliced exons and RBM20 binding was found
to peak 50 nt upstream and 100 nt downstream of repressed
exons. Using RBM20-RRM in our binding assays we iden-
tified the region downstream of the repressed exon to be
most strongly bound by RBM20 and no significant bind-
ing to the upstream intron of the repressed exon (Figure
4). This might relate to the averaging of consensus sites
over the transcriptome versus the analysis of an individual
exon: RBM20 might employ slightly different mechanisms
for alternative exon repression versus mutually exclusive ex-
ons selection. Indeed, the presence of additional upstream
RBM20 binding sites could thus relate to alternative splic-
ing of mutually exclusive exons. An alternative explanation
might be the differential binding of full length RBM20 ver-
sus the truncated isoform. Nevertheless, RNA-binding and
repression are not directly connected, as exon 242 contains
binding sites for RBM20 interacting proteins that can sup-
port the repressor activity of RBM20. An example is the
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
(gray)/-globin (blue) hybrid splicing reporters used to evaluate PTB4
effect on titin splicing regulation. (B) PTB4-mediated changes in the al-
ternative splicing of the human titin/-globin hybrid splicing reporter
X11Changes in X11 alternative splicing were assayed in the background of
RBM20. Increasing concentrations of PTB4 reverted the repressor activity
of RBM20 onX11 splicing reporter. Titin-derived sequences missing splic-
ing reporter (BG) was not responding to RBM20 or PTB4 (indicated on
the right). (C) qRT-PCR (SYBRGreen) quantification of PTB4-regulated
alternative splicing events in the titin/-globin mutant splicing reporter: n
= 3; ***P < 0.001. (D) Schematic representation of the RNA transcripts
used to study PTB4 binding. Black boxes indicate UCUU binding motifs.
C1 transcript contains two UCUU binding motifs, organized in tandem,
C2 contains one UCUU binding motif, C3 contains no UCUU binding
motif and the C4 transcript contains two separated UCUU binding mo-
tifs. (E) RNA–protein complex formation as analyzed in a gel-shift assay.
Black arrows indicate the observed formation of RNA–protein complexes.
PTB4 binds all transcripts except for C3 that does not contain the consen-
sus site. (F) RNA–protein complex formation analyzed by gel-shift assay
using RBM202 and PTB4 protein. Black arrows indicate the formation
of RNA–protein complexes. Increasing the concentration of PTB4 pro-
motes the generation of additional RNA/protein complexes and leads to
a reduction of RBM202/RNA complexes.
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Figure 7. Model for the regulation of TTN241-3 splicing by RBM20 and
PTB4. (A) In the absence of RBM20, spliceosomal complexes form over
the exon and over the both introns (solid arrows) to include titin exon 242.
Constitutive exons in dark gray, alternative exon 242 light gray and introns
are indicated as thin lines. (B) Model of RBM20 mediated exclusion of
exon 242: RBM20 binds downstream intron sequences and interferes with
exon 242 5′ss recognition by the U1 snRNP resulting in reduced recogni-
tion of the downstream intron. This interaction destabilizes the upstream
3′ss recognition by the U2 snRNP and interferes with the exon definition
complex and upstream intron recognition. As a result, the spliceosome rec-
ognizes only the external 5′ and 3′ splice sites and exon 242 is excluded.
Transparent arrows indicate absent or incomplete communication between
splice sites. (C) Addition of PTB4 overcomes the negative effect of RBM20
on exon retention as both factors bind the downstream intron, where they
differentially interfere with U1 snRNP and 5′ss interactions, formation of
the exon definition complex and subsequent inclusion of the alternative
exon.
RBM20-interacting protein FUS (15), which is predicted to
bind titin exon 242 (RBPDB search (22)). A similar arrange-
ment was recently described for splicing regulator RBfox
that acts as part of a large complex of RNA-binding pro-
teins (LASR) to stimulate splicing repression (23).
We found that the 5′ and 3′ splice sites of the flanking ex-
ons 241 and 243 did not contribute to the alternative splic-
ing of exon 242, as their exchange for -globin exons did
not affect RBM20-dependent isoform expression (Figure
2). The minimal genomic segment required for RBM20-
mediated exon repression includes the alternative exon and
flanking intronic region. Together with the information on
RBM20 binding, this data would be consistent with the
molecular mechanism summarized in Figure 7. Binding of
RBM20 to the downstream intron suggests that repression
is achieved by interfering with intron definition. We find the
3′ss of exon 242 and the upstream intron sequences nec-
essary for the repression, implying an even earlier role of
RBM20––already at the level of spliceosome assembly dur-
ing exon definition. This model suggests that inefficient re-
cruiting of the spliceosome to the 5′ss of exon 242 would
affect recognition of the upstream 3′ss needed to define the
exon. Here, splicing repression would result from the poorly
defined exon 242 3′ss and involve the inhibition of spliceo-
some assembly over the upstream intron (Figure 7B).
Diverse mechanisms of splicing repression have been de-
scribed. Among them is binding of PTB at sites overlapping
with splicing signals (polypyrimidine tract or branch point)
and steric blockage of splicing factor access (24,25). An-
other scenario of PTB splicing repression requires binding
to sequences located in both flanking introns and cooper-
ative interaction between PTB molecules, with subsequent
looping out of the intervening region or to its silencing by
coating it with PTBmolecules (19,26). Binding to an exonic
splicing silencer and targeting molecular events that lead
to exon definition (inhibiting the association of U2AF and
U2 snRNP with the upstream 3′ss, without affecting recog-
nition of the downstream 5′ss by the U1 snRNP) is used
by PTB to exclude Fas exon 6 and generate mRNA encod-
ing a soluble isoform of a receptor (18). Neuron-specific al-
ternative splicing factors (Nova proteins) block U1 snRNP
binding and inhibit exon inclusion by binding to an ex-
onic YCAY cluster (20). Muscleblind-like 1 (MBNL1) pro-
tein binds to a structured intronic silencer to compete with
U2AF65 binding and to repress cardiac troponin T exon 5
(22). hnRNP L together with hnRNP A1 repress spliceo-
some assembly and subsequently splicing of CD45 exon 4
by promoting aberrant U1 snRNA binding with exonic se-
quences upstream of the 5′ss (24). For RBM20 the details
of the exon repression mechanism were unknown.
Here, we uncovered that RBM20 upon binding its func-
tional response element in the downstream intron prevents
removal of upstream and downstream introns and thus in-
hibits alternative exon inclusion. A similar mechanism has
been described for activation of alternative exon inclusion
by MBNL1 as binding of MBNL1 to its functional re-
sponse element in the downstream intron and enhancing
U2AF65 binding and splicing of the upstream intron leads
to the inclusion of insulin receptor exon 11 (27). This mech-
anism relates to activation of exon inclusion, but has––to
our knowledge––so far not been described for inhibition as
described here for RBM20.
Toward understanding how splice factors concertedly
shape cardiac isoform expression, we identified PTB4 as
a novel titin splicing regulator that counteracts the splice
repressor activity of RBM20. Interestingly, PTBP1 and
RBM20 are both expressed from the late embryonic stages
to the adulthood (Supplementary Figure S6J and (10)). In
addition, we find that PTB4 andRBM20 bind the samemo-
tive on the 5′SS downstream of the alternative exon. Thus,
we do not only show for the first time that PTB isoforms
bind to titin-derived mRNA, but provide a possible mech-
anism of regulating titin isoform expression through addi-
tive binding of PTB and RBM20 to the downstream intron.
Building on these findings, our future work will compare
the titin splice regulators RBM20 and PTB4 as therapeu-
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tic targets to adapt cardiac isoform expression and improve
diastolic function in patients with heart disease.
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